Medifast (NYSE: MED) reported Q4 EPS of $2.36, $0.02 worse than the analyst estimate of $2.38. Revenue for the quarter came in at $264.9 million versus the consensus estimate of $244.49 million.

For earnings history and earnings-related data on Medifast (MED) click here.